Genetic variant located on chromosome 17p12 contributes to prostate cancer onset and biochemical recurrence.
Ontology highlight
ABSTRACT: The genetic contribution to prostate cancer (PC) onset and clinical heterogeneity has an important impact on the disease stratification accuracy. Despite the fact that radical prostatectomy (RP) is an effective treatment for localized PC, a considerable number of individuals develop biochemical recurrence (BCR) following surgery. In the present study, we decided to investigate the significance of genetic variability in a homogeneous group of Romanian men and to determine if genotyping could provide information regarding the possible implications of rs4054823 susceptibility loci in PC progression and outcome. A total of 78 samples from both PC and benign prostatic hyperplasia (BPH) patients were genotyped. The genotype frequencies were examined to see if there was a link between the 17p12 S
SUBMITTER: Pavel AG
PROVIDER: S-EPMC8927158 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA